Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Investors in the Biotech industry have had a rough few weeks. The benchmark SPDR S&P Biotech ETF (NYSEARCA: XBI )has fallen 26% since peaking in February of this year. However, Atossa Therapeutics (NASDAQ: ATO...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips One of my favorite InvestorPlace commentators is Josh Enomoto. He tells it like it is while providing a balanced analysis. For example, Enomoto recently discussed seven penny stocks getting lots of attention from the...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Trending slightly up once again, should you dive into former Reddit favorite Atossa Therapeutics (NASDAQ: ATOS ) stock? Not so fast. Sure, it may still have high short-interest ( 18.7% of float as of Aug 12 ). The b...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips This is the first time I’m writing about Atossa Therapeutics (NASDAQ: ATOS ) stock and in doing my research, I felt like the company’s story was one I heard before. Source: luch...
Best Penny Stocks on Robinhood to Watch For Under $4 Finding penny stocks on Robinhood is a great way to stay ahead in the stock market. While many investors believe that penny stocks are only traded on OTC markets, but it is actually quite the opposite. In reality, a penny stock is...
3 High Volume Biotech Penny Stocks to Watch Right Now Over the past year and a half, biotech penny stocks have seen higher volume than average. This is the result of many factors in combination with one another. However, the largest impacting factor on biotech penny stocks during th...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips In the years leading up to the novel coronavirus pandemic, financial advisors bemoaned that younger people weren’t investing in their future as did prior generations. However, the lockdowns and government stimulus ch...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Atossa Therapeutics (NASDAQ: ATOS ) is a clinical-stage biotech company whose surge in 2021 soon proved to be unsustainable. It underwent a meteoric rise from $1.52 in April to a 52-week high of $9.80 in June. But now...
SEATTLE, Aug. 13, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in oncology and infectious disease with a current focus on breast cancer and COVID-19, today announces financi...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips The mania surrounding penny stocks — related to the “meme stocks” and Reddit stocks trend — is taking a breather right now. But does that mean this is an area to stay away from when it comes to...
News, Short Squeeze, Breakout and More Instantly...
Atossa Therapeutics Inc. Company Name:
ATOS Stock Symbol:
NASDAQ Market:
Atossa Therapeutics Inc. Website:
SEATTLE, July 22, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) today announced that the 12-patient 80mg pharmacokinetic (PK) run-in cohort of the Phase 2 EVANGELINE (Endoxifen Versus exemestANe GosEreLIn) study has fully...